Your browser doesn't support javascript.
loading
[Usefulness of Immunostaining Scoring for Predicting Response to Single-Agent Nivolumab in Patients with Metastatic Renal Cell Carcinoma].
Wakamiya, Takahito; Kubo, Terufumi; Yamashita, Shimpei; Kohjimoto, Yasuo; Torigoe, Toshihiko; Hara, Isao.
Affiliation
  • Wakamiya T; The Department of Urology, Wakayama Medical University.
  • Kubo T; The Department of Pathology, Sapporo Medical University School of Medicine.
  • Yamashita S; The Department of Urology, Wakayama Medical University.
  • Kohjimoto Y; The Department of Urology, Wakayama Medical University.
  • Torigoe T; The Department of Pathology, Sapporo Medical University School of Medicine.
  • Hara I; The Department of Urology, Wakayama Medical University.
Hinyokika Kiyo ; 68(10): 311-315, 2022 Oct.
Article in Ja | MEDLINE | ID: mdl-36329378
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Agents, Immunological / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: Ja Journal: Hinyokika Kiyo Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Agents, Immunological / Kidney Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: Ja Journal: Hinyokika Kiyo Year: 2022 Type: Article